scholarly journals Experimental substantiation of novocaine therapy for threatened abortion

2021 ◽  
Vol 43 (6) ◽  
pp. 48-50
Author(s):  
O. V. Maslovskaya
Keyword(s):  
Termination Of Pregnancy ◽  
Favorable Result ◽  
Uterine Contractions ◽  
Vascular Bed ◽  
Threatened Abortion ◽  
Experimental Substantiation

Published in 1955 by R.A.Vortapetov and P.G.Zhuchenko data on the favorable result of treatment with novocaine in 80 women with threatening termination of pregnancy prompted us to experimentally study the nature of the effect of novocaine introduced into the vascular bed on the intensity of uterine contractions

scholarly journals The use of the drug "duphaston"in women with a history of miscarriage to prepare for pregnancy and treat the threat of termination of pregnancy

2002 ◽  
Vol 51 (2) ◽  
pp. 54-56
Author(s):  
T. A. Pluzhnikova
Keyword(s):  
Menstrual Cycle ◽  
Luteal Phase ◽  
High Efficiency ◽  
Fetal Loss ◽  
Termination Of Pregnancy ◽  
History Of ◽  
Threatened Abortion

The aim of the study was to evaluat`e the use of the drug duphaston: 1) to prepare for an upcoming pregnancy in women with hyperandrogenism and insufficiency of the luteal phase of the cycle; 2) to treat the threat of termination of pregnancy in women with a history of miscarriage. The use of duphaston in women suffering from miscarriage has confirmed its high efficiency both in preparation for pregnancy in patients with hyperandrogenism and insufficiency of the luteal phase of the menstrual cycle, and in the treatment of threatened abortion. In 93.5% of women with a history of 100% fetal loss, it was possible to bring the pregnancy to delivery.

Measurement Invariance of the Parent Version of the Strengths and Difficulties Questionnaire (SDQ) Across Community and Clinical Populations

2018 ◽  
Vol 34 (4) ◽  
pp. 238-246 ◽  
Author(s):  
Iris A. M. Smits ◽  
Meinou H. C. Theunissen ◽  
Sijmen A. Reijneveld ◽  
Maaike H. Nauta ◽  
Marieke E. Timmerman
Keyword(s):  
Measurement Invariance ◽  
Clinical Sample ◽  
Community Sample ◽  
Strengths And Difficulties Questionnaire ◽  
Emotional And Behavioral Problems ◽  
Clinical Settings ◽  
Favorable Result ◽  
Strengths And Difficulties ◽  
Parent Version ◽  
Clinical Populations

Abstract. The Strengths and Difficulties Questionnaire (SDQ) is a popular screening instrument for the detection of social-emotional and behavioral problems in children in community and clinical settings. To sensibly compare SDQ scores across these settings, the SDQ should measure psychosocial difficulties and strengths in the same way across community and clinical populations, that is, the SDQ should be measurement invariant across both populations. We examined whether measurement invariance of the parent version of the SDQ holds using data from a community sample (N = 707) and a clinical sample (N = 931). The results of our analysis suggest that measurement invariance of the SDQ parent version across community and clinical populations is tenable, implying that one can compare the SDQ scores of children across these populations. This is a favorable result since it is common clinical practice to interpret the scores of a clinical individual relative to norm scores that are based on community samples. The findings of this study support the continued use of the parent version of the SDQ in community and clinical settings.

ZUR BEDEUTUNG DES HYPOPHYSÄREN LUTEINISIERUNGSHORMONS FÜR SCHWANGERSCHAFT, GEBURT UND LACTATION BEI DER RATTE

1970 ◽  
Vol 65 (3_Suppl) ◽  
pp. S5-S32 ◽  
Author(s):  
K. Loewit
Keyword(s):  
Luteinizing Hormone ◽  
Early Pregnancy ◽  
Hydroxysteroid Dehydrogenase ◽  
The State ◽  
Termination Of Pregnancy ◽  
Progesterone Level ◽  
Corpora Lutea ◽  
Regulatory Properties ◽  
Duration Of Pregnancy

ABSTRACT The role of luteinizing hormone (LH) for the maintenance of pregnancy, parturition and lactation was investigated by immunological and histochemical methods in the rat. Neutralisation of endogenous rat-LH with Rabbit-Anti-Bovine-LH-Serum (selective hypophysectomy) from days 7-12 of pregnancy resulted in reabsorption of the foetuses and the reappearance of strong 20α-hydroxysteroid-dehydrogenase (20α-OHSD) activity in the corpora lutea (CL) of pregnancy, which normally show no such activity at that time. This effect could be prevented in part by concurrent pregnenolone administration and fully by progesterone, but was not influenced by oestrogen or prolactin. It is concluded that in early pregnancy LH is the main luteotrophic hormone in the rat even though prolactin might act synergistically with it. Antiserum treatment after the 12th day of gestation had no influence on the state or duration of pregnancy or on parturition. LH-injections during the first half of pregnancy had no luteolytic effects i. e. they did not activate 20α-OHSD activity. After day 16 they advanced the reappearance of the enzyme, but delayed parturition or resulted in stillbirths. Neither LH nor antiserum seemed to alter lactation. Since progesterone prevented both the termination of pregnancy and the recurrence of 20α-OHSD activity, it should have some regulatory properties on the enzyme. It is discussed whether the gonadotrophin-dependent progesterone level could regulate the 20α-OHSD activity rather than result from it.

Sign in / Sign up

Export Citation Format

Share Document